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doi:10.1016/j.ejvs.2011.01.013Abstract Objectives: Spontaneous embolisation (SE) detected using Transcranial Doppler
(TCD) after a Transient Ischaemic Attack (TIA)/Minor stroke is an independent predictor of
recurrent stroke. There are, however limited data on the differential prevalence of SE in
the first few days/weeks after onset of symptoms.
Method: 156 consecutive patients (symptomatic n Z 123, asymptomatic n Z 33) underwent
Carotid Endarterectomy (CEA) during an 18 month period and had an accessible window
permitting 30 min of pre-operative TCD monitoring. A prospective study was conducted with
assessors blinded to clinical status.
Results: Spontaneous embolisation was detected in 31 symptomatic patients (25%) of which
1/1 (100%), 14/35 (40%), 8/37 (22%) and in 8/50 (16%) patients presented within 48 h, 3e7
days, 8e14 days and >14 days respectively from the index clinical event. SE occurred in only
6% of asymptomatic patients. Out of 31 symptomatic patients with SE, seven (22.6%) suffered
recurrent cerebrovascular events following admission as opposed to 11/92 patients (11.9%)
who had no evidence of spontaneous embolisation after admission (OR 2.2 (95% CI
0.8e6.1))(P Z 0.2)
Conclusion: Patients presenting for CEA in the hyperacute period after onset of TIA/Minor
stroke have a high incidence of SE. Patients with SE had a 23% risk of recurrent cerebrovascular
events. These data support the current drive towards expedited CEA in recently symptomatic
patients.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’
162523252; fax: þ44 1162523179.
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Embolisation of atherothrombotic material from an extra-
cranial carotid stenosis is responsible for up to one third of
all strokes.1 Recent evidence suggests that the highest risk
of recurrent stroke (after the index transient ischaemic
attack (TIA) or minor stroke) is during the first seven days.2
This has been the impetus underlying the move towards
expedited/emergency carotid endarterectomy (CEA).
The detection of emboli in the ipsilateral middle cere-
bral artery (MCA) using Transcranial Doppler (TCD) has been
associated with a nine-fold increase in stroke risk.3
However, to date few large scale studies have evaluated
the prevalence of spontaneous embolisation in the acute
and hyperacute period after onset of a TIA or minor stroke
and then correlated this with the risk of early recurrent
cerebrovascular symptoms. Following a reconfiguration of
vascular surgery and stroke medicine services in October
2008, a rapid access TIA service was established operating
everyday of the year.4 Symptomatic patients found to have
an ipsilateral stenosis >50% were transferred directly to the
Vascular Unit for urgent CEA. This practice has ensured that
78% of Leicester patients coming through the new TIA clinic
undergo CEA within 14 days of the index event, with 43%
within 7 days.
The hypothesis underlying the current study was that
TCD-detected spontaneous cerebral embolisation would be
more prevalent in patients who were acutely symptomatic
and that patients with spontaneous cerebral embolisation
would have a higher rate of early recurrent cerebral isch-
aemic events. If true this would further support the drive
towards expedited CEA in acutely symptomatic patients with
carotid artery disease.
The aim of the study was to correlate patterns of spon-
taneous embolisation (SE) with the risk of suffering recurrent
cerebral ischaemic events (new onset Stroke, TIA, or episode
of Amaurosis Fugax).
Materials and Methods
The current study was authorised by the Leicestershire,
Northamptonshire and Rutland Ethics Committee.
One hundred and seventy two patients undergoing CEA
between August 2008 and March 2010 (including asymp-
tomatic patients) were included in the study after giving
informed consent. Sixteen patients were excluded (no
temporal window for TCD) leaving 156 for inclusion in the
study (symptomatic n Z 123, asymptomatic n Z 33).
Patients were included in the study if they were undergoing
a carotid endarterectomy for a critical stenosis (>50%
NASCET if symptomatic, >70% NASCET is asymptomatic) of
the carotid artery during the study period. Patients were
excluded if they were found to have any other probable
cause of embolic cerebrovascular disease e.g. atrial fibril-
lation; or if there was not an accessible cranial window
permitting transcranial Doppler (TCD) monitoring of the
ipsilateral middle cerebral artery.
In addition to physically starting bestmedical therapy and
risk factor control (anti-platelet, antihypertensive, antiar-
rhythmic, statin therapy etc) within the rapid access TIA
clinic, patients found to have a 50e99% ipsilateral stenosiswere then transferred immediately to the Vascular Surgery
Unit at the Leicester Royal Infirmary for expedited CEA.
Patients were defined as being clinically symptomatic if
they reported a stroke, TIA or Amaurosis Fugax in the
territory of the ipsilateral stenosed internal carotid artery
within the preceding 6 months. As soon as possible after
admission (same day if admitted before 5pm or next day if
admitted after 5pm) in symptomatic patients or at the time
of pre-assessment for asymptomatic patients, a 30 min
period of TCD monitoring was performed using a commer-
cially available TCD machine (Sonara TCD System from Via-
sys Healthcare) with the 2-MHz head probe held in place by
an external fixation device. Insonation of the ipsilateral MCA
was achieved via the temporal acoustic window at a depth of
50e60 mm using a 2-MHz pulsed Doppler transducer. The
sample volume (generally 8e13 mm), power and gain were
adjusted to ensure an optimal embolic signal to background
signal relationship. Each embolic signal was recorded and
categorised using the Consensus Committee Criteria5 to
differentiate between true emboli and other high intensity
transient signals (HITS), including artefacts. Patients were
classed as having evidence of SE if one or more embolic
signal found to be of a true emboli were detected in the
30 min monitoring period. Each TCD recording was made by
a trained vascular technologist who was blinded to data
regarding timing of the clinical event in symptomatic
patients. Statistical analysis was performed using SPSS
(v16). Statistical tests used included Fishers Exact test and
student t-test to determine P values. Guidance was sought
from the departmental medical statistician.
Following admission, all patients underwent a second
Duplex assessment (in line with HTA guidelines6). Patients
with uncontrolled hypertension started treatment as soon
as possible with the aim of getting the systolic BP below
160 mmHg wherever possible. It was the aim of the service
to only delay CEA if the hypertension did not respond to
treatment and remained excessively high (>190 mmHg
systolic BP) and if there was no evidence of spontaneous
embolisation on TCD.
The unit also aimed to offer expedited CEA to all
patients who presented with a minor stroke provided they
fulfilled the following criteria; (1) Rankin score 0e2, (2) no
internal carotid artery (ICA) occlusion, (3) no evidence of
haemorrhage on CT/MRI, (4) infarction <1/3 of the MCA
territory, (5) patient not obtunded. Stroke patients with
a Rankin score 3 only underwent urgent CEA if they had
recurrent symptoms while in hospital and then only after
discussion with the stroke physicians and anaesthetists.
The Vascular Surgery Unit maintains two half day oper-
ating lists (Tuesday/Friday) for performing expedited CEA.
CEA procedures were performed by the consultant allocated
to that particular list (i.e. this could be different to the
consultant admitting the patient). The emergency theatre
was only used if these listswere alreadyfilledor if thepatient
had evidence of spontaneous cerebral embolisation on TCD.
In the 33 asymptomatic patients, aspirin and statin
therapy was started in the outpatient clinic. In the 123 re-
cently symptomatic patients, aspirin and statin therapy was
started as soon as possible after onset of symptoms. All
patients physically received 300 mg aspirin and 40 mg
simvastatin in the TIA clinic, in addition to other appro-
priate secondary prevention therapy, and these were then
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the aspirin dose was reduced to 75 mg following transfer to
the Vascular Surgery Unit. All patients received 75 mg clo-
pidogrel the night before surgery in addition to their regular
aspirin.7 Patients who were not referred through the
Leicester TIA clinic (i.e.) from outside of Leicestershire,
and who had not been started on aspirin and statin therapy
from the referral centre (n Z 7) were commenced on
aspirin (75 mg) and simvastatin (40 mg) on admission to the
vascular surgery unit.
A recurrent cerebral ischaemic event was defined as any
patient suffering a stroke, TIA or episode of amaurosis
fugax between admission to the vascular surgery unit and
time of surgery. All patients received a routine neurological
examination at 30 days post-operatively by a consultant
stroke physician. Any patient suspected of having suffered
a pre/intra/post-procedural stroke underwent a repeat CT
scan, extra-cranial Duplex ultrasound examination and
intracranial transcranial Doppler ultrasound assessment as
soon as possible after onset of symptoms and was reviewed
by a stroke physician. All patients were seen by a consul-
tant vascular surgeon prior to surgery on a daily basis to
monitor for episodes of amaurosis fugax and TIAs, with
a repeat neurological examination performed on patients
suspected of having a recurrent cerebral ischaemic event.Results
Between August 2008 and March 2010, 156 patients under-
going CEA with an accessible TCD window were entered
prospectively into the study. One hundred and twenty three
were recently symptomatic {stroke n Z 29 (24%), TIA
n Z 73 (59%), amaurosis fugax n Z 21 (17%)}. Thirty three
were neurologically asymptomatic. Patient demographics
are detailed in Table 1.
This study found that symptomatic patients had
a significantly higher prevalence of SE than asymptomatic
patients {31/123 (25%) vs. 2/33 (6%)} {OR 5.2 95% CI
1.2e23.1} (PZ 0.02). This is consistent with the findings of
other studies.8
In 31 symptomatic patients found to be spontaneously
embolising 1/1 (100%), 14/35 (40%), 8/37 (22%) and 8/50
(16%) patients presented within 48 h, 3e7 days, 8e14 days
and >14 days respectively from the index clinical event.Table 1 Patient demographics.
Patient demographics Symptomat
Male 87 (71%)
Female 36 (29%)
Age (median) 72 (37e94
Hypertension 83 (67%)
Hypercholesterolaemia 97 (79%)
Diabetes mellitus 25 (20%)
Ischaemic heart disease 26 (21%)
Ex/current smoker 91 (74%)
On anti-platelet therapy following admission 123 (100%)
Anti-platelet therapy pre-admission 116 (94.3%)
On statin therapy following admission 123 (100%)
On statin therapy pre-admission 116 (94.3%)When analysed according to whether surgery was per-
formed within <7 days vs. >14 days of the index event, the
prevalence of SE was significantly higher in those treated
within the earlier time frame {15/36 (42%) vs. 8/50 (16%)
(OR 3.8 95% CI 1.4e10.2) (P Z 0.01)}.
Out of 31 patients found to be spontaneously embolising,
seven (22.6%) reported recurrent cerebrovascular events
following admission as opposed to 11/92 patients (11.9%)
who had no evidence of spontaneous embolisation (OR 2.2
(95% CI 0.8e6.1)) (p Z 0.2).
In 30 min of TCD monitoring, there was no significant
difference in the mean rate of SE in the cohort that went on
to have a recurrent cerebral ischaemic event (4.5/30 min
monitoring) compared to the cohort that did not have
a recurrent cerebral ischaemic event (3.3/30 min moni-
toring) (P Z 0.376).
Table 2 details the degree of stenosis and rates of
spontaneous embolisation in patients who were symptom-
atic and asymptomatic and also details the median delay
from index symptom to CEA and the median delay from the
most recent symptom to undergoing CEA. These data were
then correlated with the risk of suffering a recurrent
cerebral ischaemic event following admission but before
undergoing surgery.
Overall, 18/123 symptomatic patients (14.6%) suffered
recurrent cerebral ischaemic events between the time of
admission and undergoing surgery, though none of these
were strokes and on each occasion the secondary (recur-
rent event) was the same as the primary clinical event
(Transient Ischaemic Attack Z 14, Amaurosis Fugax Z 4).
Patients reported events occurring prior to, during and
after TCD monitoring. Patient demographics are detailed in
Table 3 for those recently symptomatic patients that had
recurrent cerebral ischaemic events after transfer to the
vascular surgery unit. Spontaneous embolisation was
detected in 3/7 (43%) symptomatic patients who were
commenced on aspirin and statin on admission but prior to
TCD monitoring compared to 28/116 symptomatic patients
(24%) who were on aspirin and statin therapy prior to
admission (OR 2.3 (95% CI 0.5e11.1) (P Z 0.4)). In the
cohort of patients who were commenced on aspirin and
statin following admission and found to have TCD evidence
of SE, no recurrent cerebral ischaemic events occurred.
Table 4 correlates the prevalence of SE and its rela-
tionship with recurrent cerebral ischaemic events relativeic (n Z 123) Asymptomatic (n Z 33) P value
24 (73%) 0.5
9 (27%) 0.5
) 66 (52e87) 0.02
23 (70%) 0.5
23 (70%) 0.9
9 (27%) 0.9
7 (21%) 0.8
28 (85%) 0.1
33 (100%) 1
31 (94%)
33 (100%) 1
31 (94%)
Table 2 Relationship between degree of carotid stenosis determined by duplex ultrasound, presence of spontaneous emboli
and timing of emboli to clinical event.
Recently symptomatic Asymptomatic
Degree stenosis (NASCET) 50e69 70e99 70e99
n Z 19 (15%) 104 (85%) 33 (100%)
Spontaneous embolisation Yes No Yes No Yes No
2/19 (11%) 17/19 (89%) 29/104 (28%) 75/104 (72%) 2/33 (6%) 31/33
(94%)
Median time from index
symptom to carotid
endarterectomy
8 days 14 days
(95% CI
1e48 days)
8.5 days
(95% CI
5e12 days)
14 days
(95% CI
9e18.5 days)
n/a n/a
Median time from most
recent symptom to
carotid endarterectomy
8 days 12 days
(95% CI
1e34 days)
6 days
(95% CI
3e9 days)
9 days
(95% CI
7e11 days)
n/a n/a
No. with recurrent cerebral
ischaemic events
between TCD and CEA
0/2 1/17 (6%) 7/29 (24%) 10/75 (13%) 0/2 0/31
P value 1 0.23 1
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ptomatic patients with a 50e99% stenosis and a 70e99%
stenosis (n Z 104).
When all 123 recently symptomatic patients with
a 50e99% stenosis are combined, the presence of SE was
associated with a non-significant two-fold increase in the
risk of recurrent cerebrovascular events {OR 2.2 (95% CI
0.8e6.1)} (P Z 0.2 Fisher’s Exact test).
Discussion
This is one of the first studies to correlate the prevalence of
SE in the hyperacute period after suffering a TIA or minor
stroke and to then correlate patterns of SE with recurrent
cerebral ischaemic events.
This study observed that symptomatic patients had
a significantly higher prevalence of SE than asymptomatic
patients (P Z 0.02). In addition, this study observed that
the prevalence of SE was closely related to the recency of
both the index clinical symptom and the most recent clin-
ical event. There was a significantly higher incidence of SE
in patients treated within 7 days compared to those treatedTable 3 Demographics for Symptomatic patients presenting
admission to the vascular surgery unit.
Patient demographics Recurrent cerebral is
event (n Z 18)
Male 14 (78%)
Female 4 (22%)
Age (median) 70 (52e87)
Hypertension 13 (72%)
Hypercholesterolaemia 16 (89%)
Diabetes mellitus 2 (11%)
Ischaemic heart disease 7 (39%)
Ex/current smoker 13 (72%)
On anti-platelet therapy following
admission
18 (100%)
Anti-platelet therapy pre-admission 18 (100%)
On statin therapy following admission 18 (100%)
On statin therapy pre-admission 18 (100%)after 14 days from the index event (PZ 0.01). It should be
noted that patients found to have TCD evidence of SE were
prioritised for urgent surgery either on the next available
CEA list (twice weekly) or on the emergency list if space was
not available on the CEA list; i.e. the detection of sponta-
neous embolisation did influence decision making relating
to the planning of urgent surgery following admission.
The third finding of this study was the relationship
between SE, delays to surgery and the risk of recurrent
cerebral ischaemic events prior to CEA. Overall, 18/123
symptomatic patients (14.6%) suffered recurrent cerebral
ischaemic events between the time of admission and
undergoing surgery, though none of these were strokes
(Transient Ischaemic Attack Z 14, Amaurosis Fugax Z 4).
The prevalence of recurrent events was higher in patients
with 70e99% stenoses {17/104 (16%)} than in those with
50e69% stenoses {1/19 (5.3%)} (p Z 0.3).
Overall, the prevalence of recurrent cerebral ischaemic
events was twice as high in patients with TCD evidence of
SE {7/31 (23%)} than in those with no evidence of SE {11/92
(11.9%)} (OR 2.15 (95% CI 0.75e6.1) (P Z 0.2)) but this did
not reach statistical significance.with/without recurrent cerebral ischaemic events after
chaemic No recurrent cerebral ischaemic
event (n Z 105)
P value
73 (70%) 0.6
32 (30%) 0.6
73 (37e94) 0.9
71 (68%) 0.8
83 (79%) 0.5
23 (22%) 0.4
21 (20%) 0.1
77 (73%) 1
105 (100%) 1
98 (93%) 0.6
105 (100%) 1
98 (93%) 0.6
Table 4 Spontaneous embolisation in relation to time from index presenting symptom to carotid endarterectomy in recently
symptomatic patients with a 50e99% and 70e99% stenosis.
<48 h 3e7 days 8e14 days >14 days
Patients with 50e99% NASCET stenosis
All patients (n Z ) 1 (0.8%) 35
(28%)
37
(30%)
50
(41%)
Spontaneous embolisation Yes No Yes No Yes No Yes No
n Z 1/1
(100%)
0/1 14/35
(40%)
21/35
(60%)
8/37
(21.6%)
29/37
(78.4%)
8/50
(16%)
42/50
(84%)
Recurrent cerebral ischaemic
events (n Z )
0 n/a 3/14
(21%)
4/21
(19%)
1/8
(12.5%)
2/29
(6.9%)
3/8
(37.5%)
5/42
(11.9%)
P value 1 1 0.5 0.1
Patients with 70e99% NASCET stenosis
Patients (n Z ) 1 (1%) 28
(27%)
32
(31%)
43
(41%)
Spontaneous embolisation Yes No Yes No Yes No Yes No
n Z 1/1
(100%)
0/1 13/28
(46%)
16/28
(57%)
7/32
(21.8%)
25/32
(78.1%)
8/43
(18.6%)
35/43
(81.3%)
Recurrent cerebral
ischaemic events (n Z )
0 n/a 3/13
(23%)
3/16
(18.8%)
1/7
(14.3%)
2/25
(8%)
2/8
(25%)
6/35
(17.1%)
P value 1 1
0.5 0.6
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has shown a non-significant trend towards SE being
predictive of recurrent cerebral ischaemic events, espe-
cially in patients with a 70e99% stenosis. It may be that
a significant result might have become evident with greater
numbers which is accepted to be one of the study limita-
tions, but the fact that only 30 min of pre-operative TCD
monitoring was performed may also have missed patients
who were truly embolising (i.e. a type II error).
Reducing delays in admission and therefore surgery after
the index clinical event remains an important benchmark for
secondary stroke prevention. We have previously reported4
that following the introduction of a rapid access TIA clinic
in October 2008, 43% of patients in our unit now underwent
surgery within 7 days of their index clinical event. The find-
ings and clinical impact of this study is limited by the delay in
admission from index clinical event. Enhancing patient
education, and improving links between primary care and
secondary care, and between stroke physicians and vascular
surgeons is ensuring that this delay is reduced.
Although no strokes occurred prior to surgery in this
particular series, these findings are otherwise entirely
consistent with natural history studies demonstrating the
higher risk of recurrent stroke and TIA in the hyperacute
period after suffering a TIA.2,9
The landmark evidence for intervening in patients with
extra-cranial symptomatic carotid artery disease came
from The European Carotid Surgery trial (ECST)9 and The
North American Symptomatic Carotid Endarterectomy Trial
(NASCET),10 which demonstrated benefit for treating pa-
tients who reported carotid territory symptoms in the
preceding six months and who had a NASCET 50e99%
stenosis of the ipsilateral carotid artery (ECST 70e99%).
Conventional teaching has taught that the risk of stroke
after a TIA is only about 1e2% at seven days and 2e4% at 28days.11,12 The impetus for undertaking more rapid inter-
vention came from two recently published meta-analyses
by Giles and Wu.2,13 These meta-analyses showed that the
risk of stroke after a TIA was highest in the first seven days.
The meta-analyses by Giles and Wu2,13 (which were based
on natural history studies that utilised ‘face to face’ follow
up of the entire population of TIA patients) demonstrated
that at 48 h the risk of stroke increased to 6.7%, and was
10% at seven days. This represents a fourfold increase in the
early risk of stroke after a patient presented with their
index TIA when compared to conventional teaching. Anal-
ysis of the Carotid Endarterectomy Triallists Collaboration
(CETC)14 data has also allowed researchers to model the
number of strokes prevented per 1000 CEAs at 5 years in
relation to the procedural risk and delay to surgery. The
evidence from this analysis suggest that surgical interven-
tion within 14 days with a procedural risk of 10% would still
prevent more strokes at 5 years than if surgery was delayed
by four or more weeks and then performed with a proce-
dural risk of 0%.15
For these reasons, there is a drive towards undertaking
urgent/emergency treatment of TIA patients. While
guidelines from the European Vascular Surgery Society16
and the UK National Institute for Clinical Excellence
(NICE)17 now recommend that CEA should be performed
within 14 days of onset of symptoms unless contra-indi-
cated, the ultimate goal of the UK National Stroke
Strategy18 is that CEA should be regarded as an emergency
procedure and should be performed within 48 h of a TIA or
minor stroke.
The use of pre-operative TCD monitoring and detection
of SE allows for individualised patient management, in
order to prioritise treatment and meet current guidelines.
The study serves as a pilot study which can now lead to
a powered study with the possibility to do two-time point
Spontaneous Cerebral Embolisation in Recently Symptomatic Patients with TIA/Minor Stroke 725TCD measurements to determine intra-patient variation in
rate of SE in time.
In summary, therefore, this study lends further support to
natural history studies which suggest that the risk of recur-
rent cerebral ischaemic events is highest in the first few
days after onset of symptoms and that the higher rates of
SE detected during these time periods support on-going
thrombo-embolisation (despite initiation of anti-platelet
therapy) being the principle cause of these recurrent events.
These data, therefore, support the move towards expedited
CEA in patients who present with TIA or minor stroke.
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